Equities

Numinus Wellness Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Numinus Wellness Inc

Actions
Health CareMedical Equipment and Services
  • Price (CAD)0.05
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta2.8045
Data delayed at least 15 minutes, as of Feb 27 2026.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Numinus Wellness Inc. is a mental healthcare company. It focuses on advancing traditional and behavioral health treatments, including safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training develops tailored education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. It is the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

  • Revenue in CAD (TTM)5.33m
  • Net income in CAD-10.67m
  • Incorporated1962
  • Employees35.00
  • Location
    Numinus Wellness Inc393 Laurier Ave WMONTREAL H2V 2K3CanadaCAN
  • Phone+1 (604) 329-2079
  • Fax+1 (604) 329-2079
  • Websitehttps://numinus.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medicure Inc26.21m-3.43m12.84m23.00--0.7417--0.4898-0.3286-0.32862.511.660.94923.905.931,139,435.00-12.42-5.22-17.87-7.4847.6760.98-13.08-8.171.00--0.0546--0.98181.66-12.69---44.35--
Neurothera Labs Inc0.00-209.09k13.16m----3.15-----0.0116-0.01160.000.04930.00-------19.28---21.28--------------0.00-------143.95------
Innovotech Inc4.46m383.40k14.15m16.0027.234.9228.913.180.00960.00960.09230.05291.8519.327.96--15.266.1218.387.3347.1265.298.275.494.45--0.00--85.5617.35242.62--141.95--
Sirona Biochem Corp-16.37k-2.67m15.82m-----------0.0105-0.0105-0.00006-0.0134-0.0171--1.61---278.90-173.09---383.49-------1,405.28---5.73-----94.82-51.3728.52------
Numinus Wellness Inc5.33m-10.67m16.32m35.00------3.06-0.0366-0.04810.0175-0.00490.5827--3.41---116.67-77.90-231.32-88.0544.9631.24-200.23-325.94----3.02---82.02--51.75------
Hemostemix Inc0.00-3.40m16.60m-----------0.03-0.030.00-0.01880.00-------453.77-579.31---------------6.01---------4.57------
Avicanna Inc25.50m-1.88m22.62m38.00--6.82--0.8873-0.0165-0.01650.22620.02641.222.8910.84---9.02-61.54-51.98-226.7251.9549.33-7.37-150.050.3804--0.00--51.62172.8858.62---44.27--
Data as of Feb 27 2026. Currency figures normalised to Numinus Wellness Inc's reporting currency: Canadian Dollar CAD

Institutional shareholders

1.68%Per cent of shares held by top holders
HolderShares% Held
AdvisorShares Investments LLCas of 06 Feb 20265.36m1.67%
NVWM LLCas of 31 Dec 202511.06k0.00%
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.